VADUZ, Liechtenstein, Dec. 10, 2025 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop® for the treatment of acid reflux (GERD), a treatment […]
Tag: Implantica
RefluxStop® ‘Best in Class’ at Japan Foregut Conference as 5-Year Data and Extensive Safety Cohort is Presented to 120 Leading Surgeons
VADUZ, Liechtenstein, Nov. 25, 2025 /PRNewswire/ — Implantica AG (publ), a medtech company at the forefront of introducing advanced technology into the body, announced today that its innovative device, RefluxStop®, was a central highlight of […]
Implantica publishes Interim Report January
VADUZ, Liechtenstein, Oct. 31, 2025 /PRNewswire/ — RefluxStop® Nears FDA Approval – Strong Momentum Toward US Market Entry Significant events in the third quarter of 2025 Received positive feedback from the FDA on the final […]
Implantica presents the third quarter 2025 on October 31 at 15:00 CET
VADUZ, Liechtenstein, Oct. 27, 2025 /PRNewswire/ — Implantica AG (publ) invites investors to a presentation of the third quarter 2025 at 15:00 CET on October 31. The interim report for the third quarter will be […]
Implantica Successfully Completes MDSAP Recertification Audit
VADUZ, Liechtenstein, Oct. 6, 2025 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop® device for the treatment of acid reflux, a treatment […]
